Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, February 18, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - TUESDAY, JANUARY 4TH, 2022
Previous Mid Day Report Next Mid Day Report >>>

DOW 36825.99 240.93 (0.66%) | NASDAQ 15567.84 -264.96 (-1.67%) | S&P 500 4790.79 -5.77 (-0.12%)
Time of Screening : 1/4/2022 12:23:19 PM         Report Released : 1/4/2022 1:14:46 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 75% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(50 DAV)
52 Wk Hi
% From Hi
Date
Featured
Price
Featured
Pivot Point
Max Buy
AMD - NYSE
Advanced Micro Devices
$142.17 -8.07
-5.37%
$152.42 45,360,453
76.76% of 50 DAV
50 DAV is 59,091,000
$164.46
-13.55%
10/27/2021 $124.91 PP = $122.59
MB = $128.72
Most Recent Note - 1/4/2022 12:25:51 PM
G - Big loss today with higher volume is testing its 50 DMA line ($142.88) which recently acted as support. A damaging violation may trigger a technical sell signal. Prior low ($130.60) defines the next important chart support level to watch. Fundamentals remain strong after it reported Sep '21 quarterly earnings +78% on +54% sales revenues versus the year ago period.
>>> The latest Featured Stock Update with an annotated graph appeared on 12/1/2021. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M

Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
AOSL - NASDAQ - ELECTRONICS - Semiconductor - Specialized
Alpha & Omega Semicondtr
$57.59 -4.62
-7.43%
$64.00 $63.48 -9.28% 658,576
123.10%
535,000
Most Recent Note for AOSL - 1/4/2022 12:27:38 PM
This Chinese Semiconductor firm is pulling back abruptly today after getting very extended from the prior high ($43.00). Noted with caution in prior mid-day reports - "Held its ground following 6 consecutive volume-driven gains, rallying from an 8-month base. Quarterly results through Sep '21 versus the year ago periods have shown strong sales revenues and earnings increases above the +25% minimum guideline. There was a big downturn in FY '20 earnings which is not a match with the fact-based investment system's strict fundamental guideline (A criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
BAC - NYSE - BANKING - Money Center Banks
Bank Of America Corp
$48.20 +2.02
4.36%
$48.34 $48.69 -1.02% 34,870,981
78.05%
44,676,000
Most Recent Note for BAC - 1/4/2022 12:30:07 PM
Challenging its 52-week high with today's 2nd consecutive big gain while rebounding from below its 50 DMA line ($45.81). Found support above its 200 DMA line since last noted with caution in the 12/16/21 mid-day report - "Reported earnings +67% on +11% sales revenues for the Sep '21 quarter versus the year ago period. Prior quarterly and annual earnings history (C and A criteria) and sub par sales revenues growth is not a match with the fact-based investment system's fundamental guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CNM - NYSE - Bldg-Constr Prds/Misc
Core & Main Inc Cl A
$28.01 -2.77
-9.00%
$28.24 $32.54 -13.92% 1,043,105
293.01%
356,000
Most Recent Note for CNM - 1/4/2022 12:31:03 PM
Gapped down today, abruptly retreating from its 52-week high following a recent spurt of volume-driven gains. Limited history is a concern since its $20 IPO on 7/23/21.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CYBE - NASDAQ - ELECTRONICS - Scientific & Technical Instrum
Cyberoptics Corp
$45.71 -1.57
-3.32%
$49.95 $49.10 -6.90% 34,581
78.59%
44,000
Most Recent Note for CYBE - 1/4/2022 12:33:23 PM
There was a "negative reversal" after an early gain today for a new 52-week high. Found support near its 50 DMA line in recent weeks. Recent quarterly comparisons through Sep '21 showed stronger sales revenues and strong earnings increases well above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been up and down.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ESTE - AMEX - Oil&Gas-U S Expl&Prod
Earthstone Energy Inc
$12.13 +0.61
5.30%
$12.32 $13.15 -7.76% 348,119
101.20%
344,000
Most Recent Note for ESTE - 1/4/2022 12:39:11 PM
Perched within striking distance of its prior high and 52-week high. Reported +483% earnings on +169% sales revenues for the Sep '21 quarter versus the year ago period, the 3rd consecutive quarterly comparison satisfying the C criteria. Annual earnings (A criteria) had a downturn in FY '20. There is a very small supply of only 30.9 million shares (S criteria) in the public float and only 9 top-rated funds (I criteria) own its shares.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
FLNG - NYSE - Oil&Gas-Transprt/Pipelne
Flex Lng Ltd
$22.17 -0.03
-0.14%
$22.23 $25.44 -12.86% 164,186
98.91%
166,000
Most Recent Note for FLNG - 1/4/2022 12:40:02 PM
Testing support near its 50 DMA line ($21.50) since noted with caution in the 12/01/21 mid-day report - "Extended from any sound base after powering to new all-time highs with recently noted volume-driven gains. Recent quarterly comparisons through Sep '21 showed strong sales and earnings increases versus the year ago periods. There was a downturn in FY '20 annual earnings (A criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GS - NYSE - FINANCIAL SERVICES - Investment Brokerage - Nationa
Goldman Sachs Group Inc
$406.53 +11.20
2.83%
$410.28 $426.16 -4.61% 2,151,436
89.57%
2,402,000
Most Recent Note for GS - 1/4/2022 12:42:30 PM
Rebounding above its 50 DMA line and toward its 52-week high with today's 2nd consecutive volume-driven gain. Found prompt support near its 200 DMA line ($380) in recent weeks. Reported Sep '21 quarterly earnings +66% on +20% sales revenues over the year ago period. Noted with caution in the prior mid-day reports - "Reported earnings +71% on +9% sales revenues for the Jun '21 quarter versus the year ago period. Up and down annual earnings history is not a match with the fact-based investment system's fundamental guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ICLR - NASDAQ - Medical-Research Eqp/Svc
ICON plc
$290.27 -5.76
-1.95%
$297.31 $313.00 -7.26% 452,220
104.92%
431,000
Most Recent Note for ICLR - 1/4/2022 12:44:57 PM
This Ireland-based Medical - Research Equipment/Services firm is pulling back from a new all-time high and today's 2nd consecutive volume-driven loss is testing its 50 DMA line ($283.60) which recently acted as support. Prior mid-day reports cautioned members - "Reported earnings +33% on +166% sales revenues for the Sep '21 quarter versus the year ago period, its 2nd strong quarter. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Annual earnings history (A criteria) had a downturn in FY '20 but were otherwise steady."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
LBAI - NASDAQ - BANKING - Regional - Northeast Banks
Lakeland Bancorp Inc
$19.95 +0.57
2.92%
$20.00 $19.58 1.86% 127,258
88.37%
144,000
Most Recent Note for LBAI - 1/4/2022 12:46:33 PM
Hitting a new 52-week high with today's 3rd consecutive gain backed by ever-increasing volume. Reported Sep '21 quarterly earnings +111% on -71% sales revenues versus the year ago period. Fundamental concerns remain as when noted in the 6/15/17 mid-day report perched at its all-time high - "Prior earnings history has been below guidelines of the fact-based investment system."

View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
MMC - NYSE - INSURANCE - Insurance Brokers
Marsh & Mclennan
$166.47 -0.76
-0.45%
$168.29 $175.12 -4.94% 1,323,838
78.33%
1,690,000
Most Recent Note for MMC - 1/4/2022 12:49:09 PM
Slumping from its all-time high and undercutting its 50 DMA line with today's 2nd consecutive loss. Reported Sep '21 quarterly earnings +32% on +270% sales revenues versus the year ago period. Prior earnings growth was not strong and steady above the +25% minimum guideline (C criteria) in quarterly comparisons.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NDAQ - NASDAQ - DIVERSIFIED SERVICES - Business/Management Services
Nasdaq Omx Group Inc
$196.98 -5.48
-2.71%
$201.84 $214.96 -8.36% 603,056
88.68%
680,000
Most Recent Note for NDAQ - 1/4/2022 12:52:33 PM
Pulling back recently after wedging near its all-time high, slumping below its 50 DMA line again and testing prior lows in the $196 area with today's 2nd consecutive volume-driven loss. Reported earnings +16% on -4% sales revenues for the Sep '21 quarter versus the year ago period. The 11/12/21 mid-day report last cautioned members - "Prior quarterly comparisons showed earnings increases below the +25% minimum guideline (C criteria) with sub par sales revenues growth. Fundamental concerns remain."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NTR - NYSE - Chemicals-Agricultural
Nutrien Ltd
$71.52 -4.60
-6.04%
$76.72 $77.35 -7.54% 3,123,806
161.02%
1,940,000
Most Recent Note for NTR - 1/4/2022 12:55:51 PM
Today's big volume-driven loss has it slumping back into the prior 7-week base and toward its 50 DMA line ($70.11). Stalled after last noted with caution in the 12/23/21 mid-day report - "Reported strong Dec '20, Mar, Jun, and Sep '21 sales and earnings results versus the year ago periods. Annual earnings history (A criteria) included a downturn in FY '19 and '20, not a match with the fundamental guidelines of the fact-based investment system."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PKI - NYSE - Medical-Research Eqp/Svc
Perkinelmer Inc
$183.96 -8.25
-4.29%
$190.47 $203.16 -9.45% 743,633
77.95%
954,000
Most Recent Note for PKI - 1/4/2022 12:59:53 PM
Abruptly retreating from its all-time high and undercutting its 50 DMA line ($184.11) with today's 2nd consecutive volume-driven loss. Wedged into new high territory after last noted with caution on 12/14/21 - "Sep '21 quarterly earnings rose +11% versus the year ago period, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. Showed resilience since dropped from the Featured Stocks list on 11/11/21."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
RACE - NYSE - Auto Manufacturers
Ferrari NV
$267.97 +8.48
3.27%
$267.98 $278.78 -3.88% 314,281
78.77%
399,000
Most Recent Note for RACE - 1/4/2022 1:01:12 PM
Today's big gain with higher volume has it challenging its all-time high. Found support near its 50 DMA line since last noted with caution in the 12/15/21 mid-day report - "Reported earnings +19% on +17% sales revenues for the Sep '21 quarter versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria) leaving concerns, fundamentally. Since completing its $52 IPO in Oct '15 its annual earnings (A criteria) history was strong until a downturn in FY '20."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SCHW - NYSE - FINANCIAL SERVICES - Investment Brokerage - Nationa
Schwab Charles Corp
$89.71 +3.95
4.60%
$89.88 $86.43 3.79% 4,442,020
86.15%
5,156,000
Most Recent Note for SCHW - 1/4/2022 1:04:47 PM
Hitting another new all-time high with today's big gain. Recently found support near its 50 DMA line ($82). Reported Sep '21 quarterly earnings +65% on +85% sales revenues versus the year ago period, its 3nd strong quarterly comparison above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history included a downturn in FY '20, a fundamental flaw with respect to the strict fact-based investment system's guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SNV - NYSE - BANKING - Regional - Mid-Atlantic Banks
Synovus Financial Corp
$50.88 +1.80
3.67%
$51.22 $50.51 0.73% 709,708
89.05%
797,000
Most Recent Note for SNV - 1/4/2022 1:06:56 PM
Clearing prior highs the $50 area with today's big gain. Found prompt support near its 200 DMA line since last noted with caution in the 10/20/21 mid-day report - "Reported earnings +30% on -4% sales revenues for the Sep '21 quarter versus the year ago period. Prior history is not a match with the fact-based investment system's fundamental guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TMO - NYSE - CONGLOMERATES - Conglomerates
Thermo Fisher Scientific
$622.54 -22.38
-3.47%
$638.03 $672.34 -7.41% 1,204,260
92.56%
1,301,000
Most Recent Note for TMO - 1/4/2022 1:09:06 PM
Pulling back abruptly from its all-time high and today's 2nd consecutive volume-driven loss is violating its 50 DMA line ($637) which previously acted as support. The prior mid-day report cautioned members - "Reported Sep '21 quarterly earnings +2% on +9% sales revenues versus the year ago period, breaking a streak of 5 strong quarterly comparisons with earnings growth well above the +25% minimum guideline (C criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TW - NASDAQ - Financial Svcs-Specialty
Tradeweb Markets Cl A
$93.47 -3.00
-3.11%
$96.76 $102.33 -8.66% 577,918
93.97%
615,000
Most Recent Note for TW - 1/4/2022 1:11:45 PM
Abruptly retreating from its all-time high with today's 2nd consecutive volume-driven loss violating its 50 DMA line ($95.24) and undercutting the prior low ($92.20 on 12/06/21). Reported earnings +30% on +25% sales revenues for the Sep '21 quarter versus the year ago period. Three of the past 4 quarterly comparisons were above the +25% minimum earnings guideline (C criteria). Limited history remains a concern since its $27 IPO on 4/04/19 and an additional Public Offerings on 10/17/19 and 4/24/20.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ZTS - NYSE - Medical-Ethical Drugs
Zoetis Inc
$224.73 -9.30
-3.97%
$234.02 $249.27 -9.84% 1,944,715
129.39%
1,503,000
Most Recent Note for ZTS - 1/4/2022 1:14:38 PM
Pulling back from its all-time high and testing its 50 DMA line ($225) with volume-driven losses. Reported earnings +14% on +11% sales revenues for the Sep '21 quarter versus the year ago period. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Sales revenues growth rate has been mostly slow and steady. Annual earnings (A criteria) history has been steady.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us